Diagnosis and Treatment of Cancer-Related Anemia

Anemia of Chronic Disease

Weiss, G., & Goodnough, L. T. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041809 · Cited by 3,800 · see citing works

Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity

Minotti, G., Menna, P., Salvatorelli, E., Cairo, G., & Gianni, L. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.2.6 · Cited by 3,784 · see citing works

Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway.

Kaelin, W. G., & Ratcliffe, P. J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.04.009 · Cited by 3,251 · cited 1× · see citing works

A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease

Pfeffer, M. A., Burdmann, E. A., Chen, C.-Y., Cooper, M. E., de Zeeuw, D., Eckardt, K.-U., Feyzi, J. M., Ivanovich, P., Kewalramani, R., Levey, A. S., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0907845 · Cited by 2,096 · see citing works

Integration of Oxygen Signaling at the Consensus HRE

Wenger, R. H., Stiehl, D. P., & Camenisch, G. (2005) · Science's STKE · doi:10.1126/stke.3062005re12 · Cited by 1,032 · see citing works

Chemotherapy-Induced Anemia in Adults: Incidence and Treatment

Groopman, J., & Itri, L. M. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.19.1616 · Cited by 934 · see citing works

The European Cancer Anaemia Survey (ECAS): A large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients

Ludwig, H., Belle, S. V., Barrett-Lee, P. J., Birgegård, G., Bokemeyer, C., Gascón, P., Kosmidis, P., Krzakowski, M. J., Nortier, J. W. R., Olmi, P., et al. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.06.019 · Cited by 928 · see citing works

Prevalence and outcomes of anemia in cancer: a systematic review of the literature

Knight, K., Wade, S., & Balducci, L. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2003.12.008 · Cited by 878 · see citing works

Notice

McMurray, J. J. V., Parfrey, P. S., Anderson, J. W., Aljama, P., Berns, J. S., Bohlius, J., Drüeke, T. B., Finkelstein, F. O., Fishbane, S., Ganz, T., et al. (2012) · Kidney International Supplements · doi:10.1038/kisup.2012.37 · Cited by 730 · see citing works

KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease: 2007 Update of Hemoglobin Target

(2007) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2007.06.008 · Cited by 726 · see citing works

Decreased Erythropoietin Response in Patients with the Anemia of Cancer

Miller, C. B., Jones, R. J., Piantadosi, S., Abeloff, M. D., & Spivak, J. L. (1990) · New England Journal of Medicine · doi:10.1056/nejm199006143222401 · Cited by 655 · see citing works

Recombinant Human Erythropoietins and Cancer Patients: Updated Meta-Analysis of 57 Studies Including 9353 Patients

Bohlius, J., Wilson, J. S., Seidenfeld, J., Piper, M., Schwarzer, G., Sandercock, J., Trelle, S., Weingart, O., Bayliss, S. E., Djulbegović, B., et al. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj189 · Cited by 549 · see citing works

Regulation of hepcidin transcription by interleukin-1 and interleukin-6

Lee, P. L., Peng, H., Gelbart, T., Wang, L., & Beutler, E. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409808102 · Cited by 542 · see citing works

Laboratory Diagnosis of Vitamin B12 and Folate Deficiency

Snow, C. F. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.12.1289 · Cited by 516 · see citing works

Double-Blind, Placebo-Controlled, Randomized Phase III Trial of Darbepoetin Alfa in Lung Cancer Patients Receiving Chemotherapy

Vansteenkiste, J. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.16.1211 · Cited by 479 · see citing works

Effective Treatment of Cobalamin Deficiency With Oral Cobalamin

Kuzminski, A. M., Giacco, E. J. D., Allen, R. H., Stabler, S. P., & Lindenbaum, J. (1998) · Blood · doi:10.1182/blood.v92.4.1191 · Cited by 461 · see citing works

Update on adverse drug events associated with parenteral iron

Chertow, G. M., Mason, P. D., Vaage-Nilsen, O., & Ahlmén, J. (2005) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfi253 · Cited by 457 · see citing works

Cytokine-mediated regulation of iron transport in human monocytic cells

Ludwiczek, S., Aigner, E., Theurl, I., & Weiss, G. (2003) · Blood · doi:10.1182/blood-2002-08-2459 · Cited by 420 · see citing works

Erythropoietin or darbepoetin for patients with cancer

Tonia, T., Mettler, A. C., Robert, N., Schwarzer, G., Seidenfeld, J., Weingart, O., Hyde, C., Engert, A., & Bohlius, J. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003407.pub5 · Cited by 414 · see citing works

Intravenous Iron Optimizes the Response to Recombinant Human Erythropoietin in Cancer Patients With Chemotherapy-Related Anemia: A Multicenter, Open-Label, Randomized Trial

Auerbach, M., Ballard, H. S., Trout, J. R., McIlwain, M., Ackerman, A., Bahrain, H., Balan, S., Barker, L., & Rana, J. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.08.119 · Cited by 413 · see citing works

KDIGO clinical practice guidelines for bisphosphonate treatment in chronic kidney disease

Woo, K. T., & Chan, C. M. (2011) · Kidney International · doi:10.1038/ki.2011.202 · Cited by 412 · see citing works

Detection, evaluation, and management of iron-restricted erythropoiesis

Goodnough, L. T., Nemeth, E., & Ganz, T. (2010) · Blood · doi:10.1182/blood-2010-05-286260 · Cited by 410 · see citing works

Guideline for the laboratory diagnosis of functional iron deficiency

Thomas, W., Hinchliffe, R. F., Briggs, C., Macdougall, I. C., Littlewood, T. J., & Cavill, I. (2013) · British Journal of Haematology · doi:10.1111/bjh.12311 · Cited by 405 · see citing works

Renal handling of calcium and phosphate during mineralocorticoid “escape” in man

Rastegar, A., Agus, Z. S., Connor, T. B., & Goldberg, M. (1972) · Kidney International · doi:10.1038/ki.1972.107 · Cited by 397 · see citing works

Safety and efficacy of intravenous iron therapy in reducing requirement for allogeneic blood transfusion: systematic review and meta-analysis of randomised clinical trials

Litton, E., Xiao, J., & Ho, K. M. (2013) · BMJ · doi:10.1136/bmj.f4822 · Cited by 395 · see citing works

Blood Transfusions, Thrombosis, and Mortality in Hospitalized Patients With Cancer

Khorana, A. A., Francis, C. W., Blumberg, N., Culakova, E., Refaai, M. A., & Lyman, G. H. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.21.2377 · Cited by 368 · see citing works

Trends in blood folate and vitamin B-12 concentrations in the United States, 1988–2004

Pfeiffer, C. M., Johnson, C. L., Jain, R. B., Yetley, E. A., Picciano, M. F., Rader, J. I., Fisher, K. D., Mulinare, J., & Osterloh, J. (2007) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.3.718 · Cited by 304 · see citing works

American Society of Clinical Oncology/American Society of Hematology Clinical Practice Guideline Update on the Use of Epoetin and Darbepoetin in Adult Patients With Cancer

Rizzo, J. D., Brouwers, M. C., Hurley, P. A., Seidenfeld, J., Arcasoy, M. O., Spivak, J. L., Bennett, C. L., Bohlius, J., Evanchuk, D. M., Goode, M. J., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.29.2201 · Cited by 303 · see citing works

Subcutaneous Compared with Intravenous Epoetin in Patients Receiving Hemodialysis

Kaufman, J. S., Reda, D. J., Fye, C. L., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808273390902 · Cited by 300 · see citing works

Effects of erythropoietin on platelet reactivity and thrombopoiesis in humans

Stohlawetz, P. J., Dzirlo, L., Hergovich, N., Lackner, E., Mensik, C., Eichler, H. G., Kabrna, E., Geissler, K. H., & Jilma, B. (2000) · Blood · doi:10.1182/blood.v95.9.2983.009k27_2983_2989 · Cited by 297 · see citing works

Autoimmune hemolytic anemia in chronic lymphocytic leukemia: clinical, therapeutic, and prognostic features

Mauro, F. R., Foà, R., Cerretti, R., Giannarelli, D., Coluzzi, S., Mandelli, F., & Girelli, G. (2000) · Blood · doi:10.1182/blood.v95.9.2786.009k30_2786_2792 · Cited by 294 · see citing works

Iron and infection: the heart of the matter

Bullen, J. J., Rogers, H. J., Spalding, P. B., & Ward, C. G. (2005) · FEMS Immunology & Medical Microbiology · doi:10.1016/j.femsim.2004.11.010 · Cited by 273 · see citing works

Intravenous Ferric Gluconate Significantly Improves Response to Epoetin Alfa Versus Oral Iron or No Iron in Anemic Patients with Cancer Receiving Chemotherapy

Henry, D. H., Dahl, N. V., Auerbach, M., Tchekmedyian, S., & Laufman, L. R. (2007) · The Oncologist · doi:10.1634/theoncologist.12-2-231 · Cited by 264 · see citing works

Correlation between cardiovascular disease and diabetes mellitus: current concepts

Nesto, R. W. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2003.10.016 · Cited by 232 · see citing works

Cancer- and Chemotherapy-Induced Anemia

Rodgers, G. M., Becker, P. S., Blinder, M. A., Cella, D. F., Chanan-Khan, A. A., Cleeland, C. S., Coccia, P. F., Djulbegović, B., Gilreath, J. A., Kraut, E. H., et al. (2012) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2012.0064 · Cited by 230 · see citing works

Survival of red blood cells after transfusion: a comparison between red cells concentrates of different storage periods

Luten, M., Roerdinkholder‐Stoelwinder, B., Schaap, N. P., DeGrip, W. J., Bos, H. J., & Bosman, G. J. C. G. M. (2008) · Transfusion · doi:10.1111/j.1537-2995.2008.01734.x · Cited by 226 · see citing works

Darbepoetin Alfa for the Treatment of Anemia in Patients With Active Cancer Not Receiving Chemotherapy or Radiotherapy: Results of a Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study

Smith, R. E., Aapro, M., Ludwig, H., Pintér, T., Šmakal, M., Ciuleanu, T., Chen, L., Lillie, T., & Glaspy, J. A. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.2885 · Cited by 211 · see citing works

Addition of intravenous iron to epoetin beta increases hemoglobin response and decreases epoetin dose requirement in anemic patients with lymphoproliferative malignancies: a randomized multicenter study

Hedenus, M., Birgegård, G., Näsman, P., Ahlberg, L., Karlsson, T., Lauri, B., Lundin, J., Lärfars, G., & Österborg, A. (2007) · Leukemia · doi:10.1038/sj.leu.2404562 · Cited by 198 · see citing works

Randomized, Multicenter, Controlled Trial Comparing the Efficacy and Safety of Darbepoetin Alfa Administered Every 3 Weeks With or Without Intravenous Iron in Patients With Chemotherapy-Induced Anemia

Bastit, L., Vandebroek, A., Altıntaş, S., Gaede, B., Pintér, T., Sütö, T., Mossman, T., Smith, K. E., & Vansteenkiste, J. F. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2006.10.4620 · Cited by 195 · see citing works

Induction of hypoferremia and modulation of macrophage iron metabolism by tumor necrosis factor.

Alvarez-Hernandez, X., Licéaga, J., McKay, I. C., & Brock, J. H. (1989) · PubMed · Cited by 192 · see citing works

Cancer- and Chemotherapy-Induced Anemia

_, _. (2008) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2008.0042 · Cited by 192 · see citing works

Intense Dose-Dense Sequential Chemotherapy With Epirubicin, Paclitaxel, and Cyclophosphamide Compared With Conventionally Scheduled Chemotherapy in High-Risk Primary Breast Cancer: Mature Results of an AGO Phase III Study

Moebus, V. J., Jackisch, C., Lueck, H.-J., du Bois, A., Thomssen, C., Kurbacher, C. M., Kuhn, W. C., Nitz, U. A., Schneeweiß, A., Huober, J., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.24.7643 · Cited by 192 · see citing works

Anemia, transfusion, and phlebotomy practices in critically ill patients with prolonged ICU length of stay: a cohort study

Chant, C. A., Wilson, G., & Friedrich, J. O. (2006) · Critical Care · doi:10.1186/cc5054 · Cited by 190 · see citing works

Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency: a systematic review of randomized controlled trials

Butler, C. C. (2006) · Family Practice · doi:10.1093/fampra/cml008 · Cited by 182 · see citing works

Pharmacokinetics and effects of recombinant human erythropoietin after intravenous and subcutaneous injections in healthy volunteers

McMahon, F., Vargas, R., Ryan, M., et al. (1990) · Blood · doi:10.1182/blood.v76.9.1718.1718 · Cited by 179 · see citing works

Randomized Trial of Intravenous Iron Supplementation in Patients With Chemotherapy-Related Anemia Without Iron Deficiency Treated With Darbepoetin Alfa

Pedrazzoli, P., Farris, A., Prete, S. D., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.2051 · Cited by 169 · see citing works

Reticulocyte hemoglobin content

Mast, A. E., Blinder, M. A., & Dietzen, D. J. (2007) · American Journal of Hematology · doi:10.1002/ajh.21090 · Cited by 151 · see citing works

On the relative safety of parenteral iron formulations

Chertow, G. M., Mason, P. D., Vaage-Nilsen, O., & Ahlmén, J. (2004) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh185 · Cited by 149 · see citing works

Role of c-Kit and erythropoietin receptor in erythropoiesis

Munugalavadla, V., & Kapur, R. (2005) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2004.11.005 · Cited by 128 · see citing works

Effects of erythropoietin receptors and erythropoiesis-stimulating agents on disease progression in cancer

Aapro, M., JELKMANN, W. E. B., Constantinescu, S. N., & Leyland-Jones, B. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.42 · Cited by 122 · see citing works

Phase III, Randomized Study of the Effects of Parenteral Iron, Oral Iron, or No Iron Supplementation on the Erythropoietic Response to Darbepoetin Alfa for Patients With Chemotherapy-Associated Anemia

Steensma, D. P., Sloan, J. A., Dakhil, S. R., Dalton, R. J., Kahanic, S. P., Prager, D. J., Stella, P. J., Rowland, K. M., Novotny, P. J., & Loprinzi, C. L. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.3644 · Cited by 120 · see citing works

The gut in iron homeostasis: role of HIF-2 under normal and pathological conditions

Mastrogiannaki, M., Matak, P., & Peyssonnaux, C. (2013) · Blood · doi:10.1182/blood-2012-11-427765 · Cited by 116 · see citing works

SUBCUTANEOUS COMPARED WITH INTRAVENOUS EPOETIN IN PATIENTS RECEIVING HEMODIALYSIS

Aufman, J. A. S. K., Eda, J. R., Ye, C. A. L. F., et al. (1998) · Cited by 116 · see citing works

Clinical experience with ferric carboxymaltose in the treatment of cancer- and chemotherapy-associated anaemia

Steinmetz, T., Tschechne, B., Harlin, O., Klement, B., Franzem, M., Wamhoff, J., Tesch, H., Rohrberg, R., & Marschner, N. W. (2012) · Annals of Oncology · doi:10.1093/annonc/mds338 · Cited by 113 · see citing works

The biology of pure red cell aplasia.

Dessypris, E. (1991) · PubMed · Cited by 112 · see citing works

Pure red cell aplasia associated with thymoma: clinical insights from a 50‐year single‐institution experience*

Thompson, C. A., & Steensma, D. P. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06295.x · Cited by 109 · see citing works

Intravenous iron: From anathema to standard of care

Auerbach, M., Coyne, D., & Ballard, H. S. (2008) · American Journal of Hematology · doi:10.1002/ajh.21154 · Cited by 108 · see citing works

Equilibration of Hemoglobin Concentration after Transfusion in Medical Inpatients Not Actively Bleeding

Wiesen, A. R., Hospenthal, D. R., Byrd, J. C., et al. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-121-4-199408150-00009 · Cited by 103 · see citing works

The pharmacokinetics of recombinant human erythropoietin after intravenous and subcutaneous administration to healthy subjects.

Salmonson, T., Danielson, B., & Wíkström, B. (1990) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1990.tb03692.x · Cited by 98 · see citing works

Clinical use of the total dose intravenous infusion of iron dextran.

Auerbach, M., Witt, D., Toler, W. T., Fierstein, M., Lerner, R. G., & Ballard, H. S. (1988) · PubMed · Cited by 97 · see citing works

Darbepoetin alfa 300 or 500 μg once every 3 weeks with or without intravenous Iron in patients with chemotherapy‐induced anemia

Auerbach, M., Silberstein, P. T., Webb, R. T., Averyanova, S. V., Ciuleanu, T., Shao, J. Z., & Bridges, K. R. (2010) · American Journal of Hematology · doi:10.1002/ajh.21779 · Cited by 90 · see citing works

Management of Anemia in Cancer Patients: Transfusions

Schrijvers, D. L. A. L. (2011) · The Oncologist · doi:10.1634/theoncologist.2011-s3-12 · Cited by 84 · see citing works

Studying Cancer-Related Fatigue: Report of the NCCN Scientific Research Committee

Mortimer, J. E., Barsevick, A. M., Bennett, C. L., Berger, A. M., Cleeland, C. S., DeVader, S. R., Escalante, C. P., Gilreath, J. A., Hurria, A., Mendoza, T. R., et al. (2010) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2010.0101 · Cited by 68 · see citing works

Treatment patterns and outcomes in the management of anaemia in cancer patients in Europe: Findings from the Anaemia Cancer Treatment (ACT) study

Ludwig, H., Aapro, M., Bokemeyer, C., et al. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.02.003 · Cited by 66 · see citing works

Management of cancer‐associated thrombotic microangiopathy: What is the right approach?

Werner, T. L., Agarwal, N., Carney, H. M., et al. (2006) · American Journal of Hematology · doi:10.1002/ajh.20783 · Cited by 65 · see citing works

What is causing the mortality in treating the anemia of chronic kidney disease: erythropoietin dose or hemoglobin level?

Singh, A. K. (2010) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e32833cf1d6 · Cited by 63 · see citing works

Near-elimination of folate-deficiency anemia by mandatory folic acid fortification in older US adults: Reasons for Geographic and Racial Differences in Stroke study 2003–2007

Odewole, O. A., Williamson, R. S., Zakai, N. A., et al. (2013) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.059683 · Cited by 61 · see citing works

Haematological toxicity of cranio-spinal irradiation

Jefferies, S., Rajan, B., Ashley, S. E., et al. (1998) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(98)00024-3 · Cited by 60 · see citing works

Epoetin Alfa in Patients With Advanced-Stage Hodgkin's Lymphoma: Results of the Randomized Placebo-Controlled GHSG HD15EPO Trial

Engert, A., Josting, A., Haverkamp, H., Villalobos, M., Lohri, A., Sökler, M., Zijlstra, J. M., Sturm, I., Topp, M. S., Rank, A., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.1835 · Cited by 57 · see citing works

High-Molecular Weight Iron Dextran: A Wolf in Sheep's Clothing?

Rodgers, G. M., Auerbach, M., Cella, D., Chertow, G. M., Coyne, D. W., Glaspy, J. A., & Henry, D. H. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008030255 · Cited by 56 · see citing works

Malignant histiocytosis. A phenotypic and genotypic investigation.

Cattoretti, G., VILLA, A. M., Vezzoni, P., et al. (1990) · PubMed · Cited by 51 · see citing works

Venous Thromboembolic Events and Erythropoiesis-Stimulating Agents: An Update

Dicato, M. A. (2008) · The Oncologist · doi:10.1634/theoncologist.13-s3-11 · Cited by 51 · see citing works

The Risk for Anemia with Targeted Therapies for Solid Tumors

Barni, S., Cabiddu, M., Guarneri, P., Lonati, V., & Petrelli, F. (2012) · The Oncologist · doi:10.1634/theoncologist.2012-0024 · Cited by 51 · see citing works

Effects of human marrow stromal cells on proliferation by human granulocytic (GM‐CFC), erythroid (BFU‐E) and mixed (Mix‐CFC) colony‐forming cells

Gordon, M. Y., Kearney, R. E., & Hibbin, J. A. (1983) · British Journal of Haematology · doi:10.1111/j.1365-2141.1983.00301.x-i1 · Cited by 42 · see citing works

Darbepoetin‐alfa and intravenous iron administration after autologous hematopoietic stem cell transplantation: A prospective multicenter randomized trial

Beguin, Y. P., Maertens, J. A., Prijck, B. D., Schots, R., Seidel, L., Bonnet, C. M., Hafraoui, K., Willems, É., Vanstraelen, G., Servais, S., et al. (2013) · American Journal of Hematology · doi:10.1002/ajh.23552 · Cited by 36 · see citing works

Intravenous Iron and the Risk of Infection in End‐Stage Renal Disease Patients

Perazella, M. A., Brewster, U. C., & Perazella, M. A. (2004) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2004.17115.x · Cited by 35 · see citing works

Primary Histiocytic Sarcoma of the Spleen Associated with Erythrophagocytic Histiocytosis

Audouin, J., Vercelli-Retta, J., Tourneau, A. L., et al. (2003) · Pathology - Research and Practice · doi:10.1078/0344-0338-00362 · Cited by 34 · see citing works

Cessation of intensive treatment with recombinant human erythropoietin is followed by secondary anemia

Piron, M., Loo, M., Gothot, A., et al. (2001) · Blood · doi:10.1182/blood.v97.2.442 · Cited by 31 · see citing works

Impact of limiting erythropoiesis‐stimulating agent use for chemotherapy‐induced anemia on the United States blood supply margin

Vekeman, F., Bookhart, B., White, J. T., et al. (2009) · Transfusion · doi:10.1111/j.1537-2995.2008.02072.x · Cited by 28 · see citing works

Roles for an Epo Receptor Tyr-343 Stat5 Pathway in Proliferative Co-signaling with Kit

Li, K., Miller, C. P., Hegde, S., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307182200 · Cited by 28 · see citing works

Effect of reimbursement changes on erythropoiesis‐stimulating agent utilization and transfusions

Hess, G. P., Nordyke, R. J., Hill, J. W., et al. (2010) · American Journal of Hematology · doi:10.1002/ajh.21837 · Cited by 28 · see citing works

Editorial: Intersecting Guidelines: Administering Erythropoiesis‐Stimulating Agents to Chronic Kidney Disease Patients with Cancer

Bennett, C. L., Becker, P. S., Kraut, E. H., Samaras, A. T., & West, D. P. (2008) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2008.00524.x · Cited by 22 · see citing works

Factors influencing haematological recovery following high-dose chemotherapy and peripheral stem-cell transplantation for haematological malignancies

Nieboer, P., de Vries, E. G. E., Vellenga, E., et al. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.01.029 · Cited by 22 · see citing works

Iron or vitamin B12 deficiency in anemic cancer patients prior to erythropoiesis-stimulating agent therapy

Henry, D. H., & Dahl, N. V. (2007) · Community Oncology · doi:10.1016/s1548-5315(11)70057-2 · Cited by 18 · see citing works

Myelodysplastic syndrome with pure red cell aplasia shows characteristic clinicopathological features and clonal T‐cell expansion

Wang, S. A., Yue, G., Hutchinson, L., et al. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06648.x · Cited by 17 · see citing works

Plasma free iron and chemotherapy toxicity

Beare, S., & Steward, W. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90530-9 · Cited by 17 · see citing works

Switching from subcutaneous to intravenous erythropoietin α in haemodialysis patients requires a major dose increase

Galliford, J. W., Malasana, R., & Farrington, K. (2005) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh899 · Cited by 16 · see citing works

Establishing an Anemia Clinic for Optimal Erythropoietic-Stimulating Agent Use in Hematology-Oncology Patients

Gilreath, J. A., Sageser, D. S., Jorgenson, J. A., et al. (2008) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2008.0044 · Cited by 16 · see citing works

Total Dose Iron Dextran Infusion in Cancer Patients: Is it SaFe2+?

Gilreath, J. A., Stenehjem, D. D., & Rodgers, G. M. (2012) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2012.0066 · Cited by 15 · see citing works

Evidence That Stainable Bone Marrow Iron Following Parenteral Iron Therapy Does Not Correlate With Serum Iron Studies and May Not Represent Readily Available Storage Iron

Thomason, R. W., & Almiski, M. S. (2009) · American Journal of Clinical Pathology · doi:10.1309/ajcpbay9krzf8nuc · Cited by 15 · see citing works

A Perspective on the Evolution of Management of Cancer- and Chemotherapy-Induced Anemia

Rodgers, G. M. (2012) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2012.0044 · Cited by 15 · see citing works

Erythropoiesis‐stimulating agents: friends or foes?

Shander, A., Ozawa, S., Gross, I., & Henry, D. (2013) · Transfusion · doi:10.1111/trf.12328 · Cited by 13 · see citing works

Expansion of CD34 + Cells on Telomerized Human Stromal Cells without Losing Erythroid-Differentiation Potential in a Serum-Free Condition

Kobune, M., Kawano, Y., Kato, J., et al. (2005) · International Journal of Hematology · doi:10.1532/ijh97.04080 · Cited by 11 · see citing works

Correction of Epoetin-Resistant Megaloblastic Anaemia following Vitamin B12 and Folate Administration

Breen, C. P., & Macdougall, I. C. (1999) · ˜The œNephron journals/Nephron journals · doi:10.1159/000045437 · Cited by 5 · see citing works

Re-evaluation of laboratory predictors of response to current anemia treatment regimens of erythropoiesis stimulating agents in cancer patients

Steinmetz, T., Kuhr, K., Totzke, U., Hellmich, M., Heinz, M., Neise, M., Mittermüller, J., Tessen, H.-W., Reiser, M., Severin, K., et al. (2013) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2013-0104 · Cited by 4 · see citing works

Current Practice In Diagnosis and Treatment of Chemotherapy-Induced Anemia In Five European Countries – A Patient Record Study

Beguin, Y. P., Aapro, M., Bokemeyer, C., et al. (2010) · Blood · doi:10.1182/blood.v116.21.1512.1512 · Cited by 3 · see citing works

Impact of FDA guideline changes on treatment patterns and cost among cancer patients with anemia who do not respond to erythropoietin stimulating agents (ESAs).

Girvan, A. C., Lau, Y.-K., Pohl, G. M., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.31.31_suppl.97 · Cited by 1 · see citing works

Treatment patterns among cancer patients with anemia who do not respond to erythropoietin-stimulating agents.

Girvan, A. C., Lau, Y.-K., Bowman, L., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.31.15_suppl.e20525 · Cited by 1 · see citing works

Hypoxia Signaling in Cancer: From Basics to Clinical Practice

Sebestyén, A., Kopper, L., Dankó, T., & Tímár, J. (2021) · Pathology and Oncology Research · doi:10.3389/pore.2021.1609802 · Cited by 110 · see citing works

Diagnosis of iron-deficient states

Archer, N. M., & Brugnara, C. (2015) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2015.1038744 · Cited by 82 · see citing works

Erythropoietin production in renal tumors.

Kazal, L. A., & Erslev, A. J. (1975) · PubMed · Cited by 34 · see citing works

Recombinant Erythropoietin

Spivak, J. L. (1993) · Annual Review of Medicine · doi:10.1146/annurev.me.44.020193.001331 · Cited by 29 · see citing works

Biologic and immunologic erythropoietin in extracts from hypoxic whole rat kidneys and in their glomerular and tubular fractions.

Caro, J., & Erslev, A. J. (1984) · PubMed · Cited by 67 · see citing works

Hypoxia, Erythropoietin Gene Expression, and Erythropoiesis

Ratcliffe, P. J., Eckardt, K., & Bauer, C. (1996) · Comprehensive physiology · doi:10.1002/cphy.cp040249 · Cited by 10 · see citing works

Regulation of Erythropoietin Production

Fisher, J. W. (1992) · Comprehensive physiology · doi:10.1002/cphy.cp080251 · Cited by 20 · see citing works